Hox-induced enhancement of in vivo and in vitro proliferative capacity and gene therapeutic methods
US5837507A · kind A · utility
6Cited by
2References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 13, 1995 |
| Grant date | Nov 17, 1998 |
| Priority date | — |
| Expiry date | Nov 13, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K48/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Stem cells transduced with HOXB4 exhibit enhanced in vitro and in vivo ability for self-regeneration and generate higher-numbers of tranplantable pluripotent hematopoietic stem cells relative to control and nonmanipulated cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.